Outcomes of chronic myeloid leukemia (CML) patients who stopped second generation tyrosine kinase inhibitors (2GTKIS) as second line treatment. results of the CML Spanish National Registry (RELMC)
Servizos
Servizos
Data de publicación
2012Título da revista
Blood
Tipo de contido
Publicación de congreso
